Bitcoin Forum
July 22, 2024, 05:32:10 PM *
News: Help 1Dq create 15th anniversary forum artwork.
 
   Home   Help Search Login Register More  
Pages: [1]
  Print  
Author Topic: RAPPLER VS DENGVAXIA  (Read 132 times)
playful69 (OP)
Newbie
*
Offline Offline

Activity: 78
Merit: 0


View Profile
February 21, 2018, 10:55:41 PM
 #1

isn't it ai and appalling that the YELLOW LP's are more concerned about the supposedly "suppressed press freedom" of rappler than the endangered lives of the people victimized by Dengvaxia?

the countdown of related Dengvaxia deaths are now slowly becoming alarming. the DOJ should punish the guilty and start filing criminal charges left and right.
Mometaskers
Hero Member
*****
Offline Offline

Activity: 1764
Merit: 584



View Profile
February 22, 2018, 02:12:02 AM
 #2

isn't it ai and appalling that the YELLOW LP's are more concerned about the supposedly "suppressed press freedom" of rappler than the endangered lives of the people victimized by Dengvaxia?

the countdown of related Dengvaxia deaths are now slowly becoming alarming. the DOJ should punish the guilty and start filing criminal charges left and right.

Hi, since you are talking about this, I'm assuming you are Filipino. What I'm curious is why these reports of deaths are only occurring in the Philippines when Mexico was the first to launch the vaccine and Brazil also had a significant vaccination program.

https://www.reuters.com/article/us-sanofi-dengue/trouble-mounts-for-sanofi-dengue-vaccine-over-safety-concerns-idUSKBN1DY26Y

Quote
Brazilian health regulator Anvisa, in an emailed statement to Reuters, said it had not received any reports of vaccine recipients dying or falling more severely ill because of the drug. It does not know how many people have received the vaccine in Brazil since its 2015 approval.

Quote
In addition to Brazil, the Philippines and Singapore, Dengvaxia is being sold in Mexico, Indonesia, Thailand, Paraguay, Peru, Costa Rica, El Salvador and Guatemala.

Health officials in Mexico, the first country to approve the vaccine in 2015, and in Peru had no immediate comment. Paraguay’s health officials said Dengvaxia is not widely used due to cost but that they have not received reports of problems from doctors who provide the vaccine.

It is approved but not yet launched in Honduras, Malaysia, Australia, Argentina, Venezuela, Bolivia, Bangladesh and Cambodia.

Of course there may be differences in vaccination rates so that may have affected the results.
Pages: [1]
  Print  
 
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.19 | SMF © 2006-2009, Simple Machines Valid XHTML 1.0! Valid CSS!